
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
Journal: Journal of virology
Published: June 30, 2017
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
Journal: Journal of virology
Published: February 10, 2017
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.
Journal: Science immunology
Published: January 24, 2017
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
Journal: PloS one
Published: March 15, 2016
Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection.
Journal: The Journal of allergy and clinical immunology
Published: February 03, 2016
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.
Journal: Science translational medicine
Published: October 16, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026